InBody Co.,Ltd

041830.KQ·KOSDAQ

Compare

48,250.00−550.00 (−1.12%)today

As of Oct 22, 12:53 PM KST · May be delayed up to 20 min · KRW

Key statistics

Previous close48,800.00

Open48,100.00

Day range47,100.0048,750.00

52-week range26,200.0073,500.00

Off day high−1.03%

Off 52-week high−34.35%

Volume20.16K

Avg. volume (3M)99.47K

Market cap643.97B

EPS (TTM)—

Forward P/E—

P/E ratio (TTM)—

Dividend yield—

Beta (5Y)—

Shares outstanding13.35M

Short interest—

Earnings dateAug 12, 2025 (est.)

Analyst target100,000.00

Profit margin—

Related companies

Compare ›

Companies on KOSDAQ of a similar market value (659.32B).

Company	Mkt cap	Price	Today
Hyulim ROBOT Co.,Ltd.090710.KQ	616.28B	5,140.00	−1.53%
Wonik QnC Corporation074600.KQ · Semiconductor Equipment & Materials	696.63B	26,500.00	−4.68%
Satrec Initiative Co., Ltd.099320.KQ	604.51B	55,200.00	−1.25%
Komipharm International Co., Ltd.041960.KQ	643.33B	8,950.00	−5.90%
Advanced Nano Products Co., Ltd.121600.KQ · Specialty Chemicals	725.34B	60,200.00	+0.67%
Robostar Co., Ltd.090360.KQ · Specialty Industrial Machinery	587.93B	60,300.00	−2.90%
Intellian Technologies, Inc.189300.KQ	559.10B	54,700.00	−1.26%
SFA Engineering Corporation056190.KQ · Specialty Industrial Machinery	732.35B	26,250.00	−3.49%

The stocks whose daily moves over the past year went most closely with InBody's: the correlation of their daily returns, where 1 would be moving as one.

Company	Mkt cap	Price	Today
Medy-Tox Inc.086900.KQ · Correlation 0.42	439.81B	68,100.00	−0.87%
GC Biopharma Corp.006280.KS · Correlation 0.38	1.50T	131,400.00	0.00%
Vieworks Co., Ltd.100120.KQ · Correlation 0.33	239.62B	27,850.00	−3.80%

What visitors to InBody's page also look at.

Company	Mkt cap	Price	Today
MedyTox086900.KQ	439.81B	68,100.00	−0.87%
Vieworks100120.KQ	239.62B	27,850.00	−3.80%
SEEGENE096530.KQ	1.59T	35,000.00	−3.45%
LEENO058470.KQ	4.87T	64,200.00	−4.75%
GC Biopharma Corp.006280.KS	1.50T	131,400.00	0.00%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All 041830.KQ news ›

The Asia Business Daily·Oct 13Positive

Essential Equipment in the Obesity Drug Era... InBody Scales Up [Click eStock]

Published 14 Oct.2026 07:17(KST) Updated 14 Oct.2026 08:42(KST) Securities analysts say InBody will continue to achieve structural growth in scale, driven by demand for body composition monitoring. According to SangSangin Securities on…

@PRNewswire·Oct 8Positive

Inglewood Bids to Become America's Second Blue Zone City, Powered by InBody

/PRNewswire/ -- InBody today announced the launch of a one-year fall prevention pilot with the City of Inglewood and the University of Southern California... CERRITOS, Calif., Oct. 8, 2026 /PRNewswire/ -- InBody today announced the launch…

From articles in the 4Search news index.

In the news

1mentions in 30 days

1with it in the headline

Positivesentiment

Most coverage from

asiae.co.kr1

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.

Analyst ratings

Analysis ›

—1 analysts

Strong buy 1
Buy 0
Hold 0
Sell 0
Strong sell 0

Wall Street analyst consensus. Not a recommendation.

Earnings

Reported EPS
Estimate

Next report: Tue, Aug 12, 2025 (estimated)

Quarterly results

Financials ›

Revenue
Net income
Net margin 19.3% (Q2 '26)

Prices may be delayed up to 15 min. Not investment advice.

Track record

Leaderboard ›

Days on the list	30 d	1 yr	Best
Trending	0	0	—

Not eligible for Gainers, Losers, Most active (U.S. stocks worth $2 billion or more only).

Not eligible for Small-cap gainers, Aggressive small caps (U.S. stocks worth under $2 billion only).

Not eligible for Growth tech (U.S. technology stocks only).

Not eligible for Undervalued large caps (U.S. stocks worth $10 billion or more only).

A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.